Axa
ZYME icon

Axa’s Zymeworks ZYME Stock Holding History

Axa’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-175,121
Closed -$2.2M – 1058
2025
Q2 		$2.2M Buy
+175,121
New +$2.09M 0.01% 757

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Axa's ZYME Position: Q3 2025 in Review

Axa sold out of Zymeworks (ZYME) in Q3 2025, closing a stake of 175,121 shares — an estimated $2.2M sold.

Axa first reported a position in ZYME in Q2 2025 and held it in 1 quarter. The position peaked at $2.2M in Q2 2025. 183 funds tracked by Wall St. Rank hold ZYME as of Q3 2025.

  • Axa reported no remaining Zymeworks position as of Q3 2025 after selling out during the quarter.
  • Axa sold 175,121 Zymeworks shares in Q3 2025, an estimated $2.2M.
  • Axa first reported a position in Zymeworks in Q2 2025 and held it in 1 quarter.
  • Axa's Zymeworks position peaked at $2.2M in Q2 2025.
  • 183 funds tracked by Wall St. Rank held Zymeworks as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.